ST-segment elevation in patients presenting with COVID-19: case series

Saririan, Mehrdad; Armstrong, Richard; George, Jon C.; Olechowski, Bartosz; O’Connor, Stephen; Byrd, James Brian; Chapman, Andrew R.

doi:10.1093/ehjcr/ytaa553

Cited by 17 publications

(14 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Overall, the prognosis was poor across groups with 30% in-hospital mortality rate. In accordance with the above review, M. Saririan et al [61] reported a case series where three confirmed COVID-19 positive patients with STEMI presented with negative angiographic evidence of atherothrombotic type I MI thereby suggestive of type II MI. All the three patients had patent coronary arteries on coronary angiography.…”

Section: Covid-19 With Stemi With and Without Obstructive Cadsupporting

confidence: 54%

COVID-19 and cardiovascular system—a comprehensive review

Alshahrani¹,

Hosmani²,

Shankar³

et al. 2021

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate of 31% of deaths worldwide out of which nearly 85% are due to heart attacks and stroke. Theoretically and practically, researchers have observed that persons with pre-existing cardiovascular conditions are comparatively more vulnerable to the COVID-19 infection. Moreover, they have studied the data between less severe and more severe cases, survivors and non survivors, intensive care unit (ICU) patients and non ICU patients, to analyse the relationship and the influence of COVID-19 on cardiovascular health of an individual, further the risk of susceptibility to submit to the virus. This review aims to provide a comprehensive particular on the possible effects, either direct or indirect, of COVID-19 on the cardiovascular heath of an individual.

show abstract

Section: Covid-19 With Stemi With and Without Obstructive Cadsupporting

confidence: 54%

COVID-19 and cardiovascular system—a comprehensive review

Alshahrani¹,

Hosmani²,

Shankar³

et al. 2021

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…[ 36 ]; [ 37 ]; [ 38 ]; [ 39 ]; [ 40 ]; [ 41 ]; [ 42 ]; [ 43 ]; [ 44 ]; [ 45 ]; [ 46 ]; [ 47 ]; [ 48 ].…”

Section: Uncited Referencesunclassified

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis

Jaiswal

Almas

Ang

et al. 2022

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

“…Several case studies have reported the association between COVID-19 infection and AMI [8][9][10]. Saririan et al published a case series of 3 patients with COVID-19 infection presenting with STEMI [9].They reported the incidence of myocardial injury in hospitalized patients with COVID-19 to range from 23% to 27.8%.…”

Section: Discussionmentioning

confidence: 99%

Prolonged Use of Tirofiban Infusion Without Percutaneous Coronary Intervention To Achieve Optimal Results in a COVID-19 Positive Patient With Inferior ST Segment Elevated Myocardial Infarction (STEMI) Secondary to Thromboembolism: A Case Report

Khan¹,

Patel²

2022

Cureus

View full text Add to dashboard Cite

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), responsible for COVID-19, is mainly a respiratory illness, but it can affect other organs also such as heart, kidneys, and liver. Myocardial injury from COVID-19 has been reported in hospitalized patients ranging from pericarditis and myocarditis to acute coronary syndrome (ACS). COVID-19 is highly hypercoagulable state and is associated with both central and peripheral thromboembolism. COVID 19 patients with ACS may not present with classical features of chest pain and electrocardiogram (ECG) is the most important initial investigation in these patients to assess for any ST or T waves changes. COVID-19 patients with cardiac involvement are the most vulnerable group of patients and have increased morbidity and mortality risk. COVID-19 infections can affect the cardiovascular system in patients with or without history of coronary artery disease (CAD), but the risk of type 1 or 2 myocardial infarction (MI), myocardial injury, ST segment elevation, myocarditis, heart failure, cardiogenic shock, and life threatening arrhythmias are more common in the former group. We present a case of 55-year-old patient who presented to our cardiac center with ST elevated myocardial infarction and high blood sugar level. Patient was recently diagnosed with type 2 diabetes mellitus (T2DM) but was not commenced on medications. Echocardiogram showed mildly impaired left ventricular systolic function (LVSF) with inferior wall hypokinesia, and ECG showed inferior leads ST elevation. Coronary angiogram showed severe mid-vessel lesion and occluded posterior left ventricular branch (PLV). Multiple attempts at aspirating the thrombus resulted in thrombolysis in MI grade 2 (TIMI 2) flow in the vessel and patient was commenced on a tirofiban infusion for 72 hours.

show abstract

ST-segment elevation in patients presenting with COVID-19: case series

Cited by 17 publications

References 23 publications

COVID-19 and cardiovascular system—a comprehensive review

COVID-19 and cardiovascular system—a comprehensive review

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis

Prolonged Use of Tirofiban Infusion Without Percutaneous Coronary Intervention To Achieve Optimal Results in a COVID-19 Positive Patient With Inferior ST Segment Elevated Myocardial Infarction (STEMI) Secondary to Thromboembolism: A Case Report

Contact Info

Product

Resources

About